Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anika Therapeutics (ANIK) Tax Rate (2016 - 2023)

Historic Tax Rate for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to 41.99%.

  • Anika Therapeutics' Tax Rate fell 7189200.0% to 41.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 37.58%, marking a year-over-year decrease of 939300.0%. This contributed to the annual value of 148.7% for FY2024, which is 3576700.0% down from last year.
  • Anika Therapeutics' Tax Rate amounted to 41.99% in Q3 2025, which was down 7189200.0% from 17.65% recorded in Q2 2025.
  • Anika Therapeutics' Tax Rate's 5-year high stood at 676.92% during Q3 2024, with a 5-year trough of 198.04% in Q4 2024.
  • Moreover, its 5-year median value for Tax Rate was 13.46% (2022), whereas its average is 24.86%.
  • Its Tax Rate has fluctuated over the past 5 years, first surged by 6698200bps in 2024, then plummeted by -7189200bps in 2025.
  • Anika Therapeutics' Tax Rate (Quarter) stood at 51.3% in 2021, then dropped by -23bps to 39.62% in 2022, then dropped by -9bps to 35.98% in 2023, then tumbled by -650bps to 198.04% in 2024, then skyrocketed by 79bps to 41.99% in 2025.
  • Its last three reported values are 41.99% in Q3 2025, 17.65% for Q2 2025, and 2.58% during Q1 2025.